Moderna, Inc. (MRNA) 41st Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/10/23
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government's pandemic responseMarket Watch • 01/09/23
Many Investors Wouldn't Touch This Stock With a 10-Foot Pole Last Year. Here's Why It's a Buy in 2023.The Motley Fool • 01/06/23
Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated TherapeuticsAccesswire • 01/05/23
Moderna Bolsters Its Vaccine Pipeline With $85 Million Deal for Biotech Firm OriCiroBarrons • 01/04/23
Moderna to Provide Business and Pipeline Updates at the 2023 J.P. Morgan Healthcare ConferenceAccesswire • 01/03/23